Jithendra Somaratne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jithendra Somaratne has a total of 320 co-authors. Here are the top co-authors by number of shared publications:
- Gillian A. Whalley
University of Otago, Dunedin, New Zealand
10 shared publications - Darren J. Kelly
Department of Medicine, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia
5 shared publications - Duncan John Campbell
St. Vincent’s Institute of Medical Research, Fitzroy, Australia
5 shared publications - Mary Jane Black
Monash University
5 shared publications Robert N. Doughty
14 Department of Medicine and National Institute for Health Innovation , University of Auckland , Auckland , New Zealand
5 shared publications- Alicia Josephine Jenkins
Baker Heart and Diabetes Institute, Melbourne, Australia
4 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Vol. 2026, 6647538
Use of OCT Imaging in the Treatment of Right Coronary Artery Occlusion Causing NSTEMI as an Initial Complication of Essential Thrombocythaemia
Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm characterised by clonal thrombocytosis and an overall increased risk of thrombotic events. Acute coronary syndrome as an initial presentation of ET is rare in the literature. A 39 year old woman with established ET presented with non‐ST‐elevation myocardial infarction (NSTEMI). Coronary angiography revealed a hazy, eccentric mid‐right coronary artery lesion. Optical coherence tomography (OCT) demonstrated thrombus without atherosclerotic plaque. OCT‐guided direct stenting achieved optimal expansion with thrombolysis in myocardial infarction (TIMI) Grade III flow. She was discharged on dual antiplatelet therapy and referred to haematology for ET management. At three months, she remained asymptomatic on clinic follow‐up. OCT provided diagnostic and procedural guidance in a rare thrombotic NSTEMI secondary to ET. This case highlights the role of intracoronary imaging in differentiating thrombosis from atherosclerotic plaque rupture.
- 25 February 2026
- Vol. 2026, 6647538
Open AccessUse of OCT Imaging in the Treatment of Right Coronary Artery Occlusion Causing NSTEMI as an Initial Complication of Essential Thrombocythaemia
Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm characterised by clonal thrombocytosis and an overall increased risk of thrombotic events. Acute coronary syndrome as an initial presentation of ET is rare in the literature. A 39 year old woman with established ET presented with non‐ST‐elevation myocardial infarction (NSTEMI). Coronary angiography revealed a hazy, eccentric mid‐right coronary artery lesion. Optical coherence tomography (OCT) demonstrated thrombus without atherosclerotic plaque. OCT‐guided direct stenting achieved optimal expansion with thrombolysis in myocardial infarction (TIMI) Grade III flow. She was discharged on dual antiplatelet therapy and referred to haematology for ET management. At three months, she remained asymptomatic on clinic follow‐up. OCT provided diagnostic and procedural guidance in a rare thrombotic NSTEMI secondary to ET. This case highlights the role of intracoronary imaging in differentiating thrombosis from atherosclerotic plaque rupture.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Cardiology
- Vol. 2026 (1)
Use of OCT Imaging in the Treatment of Right Coronary Artery Occlusion Causing NSTEMI as an Initial Complication of Essential Thrombocythaemia
Background: Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm characterised by clonal thrombocytosis and an overall increased risk of thrombotic events. Acute coronary syndrome as an initial presentation of ET is rare in the literature. Case Summary: A 39 year old woman with established ET presented with non‐ST‐elevation myocardial infarction (NSTEMI). Coronary angiography revealed a hazy, eccentric mid‐right coronary artery lesion. Optical coherence tomography (OCT) demonstrated thrombus without atherosclerotic plaque. OCT‐guided direct stenting achieved optimal expansion with thrombolysis in myocardial infarction (TIMI) Grade III flow. She was discharged on dual antiplatelet therapy and referred to haematology for ET management. At three months, she remained asymptomatic on clinic follow‐up. Conclusion: OCT provided diagnostic and procedural guidance in a rare thrombotic NSTEMI secondary to ET. This case highlights the role of intracoronary imaging in differentiating thrombosis from atherosclerotic plaque rupture.
- 1 January 2026
- Published by Wiley in Case Reports in Cardiology
- Vol. 2026 (1)
Open AccessUse of OCT Imaging in the Treatment of Right Coronary Artery Occlusion Causing NSTEMI as an Initial Complication of Essential Thrombocythaemia
Background: Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm characterised by clonal thrombocytosis and an overall increased risk of thrombotic events. Acute coronary syndrome as an initial presentation of ET is rare in the literature. Case Summary: A 39 year old woman with established ET presented with non‐ST‐elevation myocardial infarction (NSTEMI). Coronary angiography revealed a hazy, eccentric mid‐right coronary artery lesion. Optical coherence tomography (OCT) demonstrated thrombus without atherosclerotic plaque. OCT‐guided direct stenting achieved optimal expansion with thrombolysis in myocardial infarction (TIMI) Grade III flow. She was discharged on dual antiplatelet therapy and referred to haematology for ET management. At three months, she remained asymptomatic on clinic follow‐up. Conclusion: OCT provided diagnostic and procedural guidance in a rare thrombotic NSTEMI secondary to ET. This case highlights the role of intracoronary imaging in differentiating thrombosis from atherosclerotic plaque rupture.
- Open Access
- 26 May 2025
- Published by Elsevier in Heart, Lung and Circulation
Functional Coronary Angiography for the Diagnosis of Coronary Vasomotor Disorders
- 26 May 2025
- Published by Elsevier in Heart, Lung and Circulation
Open AccessFunctional Coronary Angiography for the Diagnosis of Coronary Vasomotor Disorders
- Open Access
- 2 May 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (6) , 103600
A Multicenter Retrospective Analysis of the Utility of Intravascular Lithotripsy in Underexpanded Stents
- 2 May 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (6) , 103600
Open AccessA Multicenter Retrospective Analysis of the Utility of Intravascular Lithotripsy in Underexpanded Stents
- 15 June 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S86
First Experience of Measuring Index of Microcirculatory Resistance at Auckland City Hospital
- 15 June 2023
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32, S86
First Experience of Measuring Index of Microcirculatory Resistance at Auckland City Hospital
- Open Access
- 10 March 2023
- Published by Pasifika Medical Association Group in New Zealand Medical Journal
- Vol. 136 (1571) , 30-40
Pharmacologic therapy among patients with type 2 diabetes mellitus admitted to the cardiology service
The New Zealand Medical Journal (NZMJ) is the principal scientific journal for the medical profession in New Zealand. The Journal has become a fundamental resource for providing research and written pieces from the health and medical industry.
- 10 March 2023
- Published by Pasifika Medical Association Group in New Zealand Medical Journal
- Vol. 136 (1571) , 30-40
Open AccessPharmacologic therapy among patients with type 2 diabetes mellitus admitted to the cardiology service
The New Zealand Medical Journal (NZMJ) is the principal scientific journal for the medical profession in New Zealand. The Journal has become a fundamental resource for providing research and written pieces from the health and medical industry.